Figure 4.
Medical treatment by patients in groups of patients depending on the dynamics of the haSTART after CABG. Notes: ARBs—Angiotensin II receptor blockers, ACEI—Angiotensin-converting-enzyme inhibitor, CCB—calcium channel blockers; *—significant differences in pairwise comparison of groups with improved haSTART and without changes haSTART; #—significant differences in pairwise comparison of groups with improved haSTART and with worsened haSTART; $—significant differences in pairwise comparison of groups without changes haSTART with worsened haSTART.
